A live cell microfluidics device utilizing phenotypic biomarkers for prostate cancer.

被引：0
|
作者：
Albala, David
Mouraviev, Vladimir
Rieger-Christ, Kimberly M.
Sullivan, Travis B.
Kella, Naveen
Knopf, Kevin B.
Rashid, Hani H.
Manak, Michael S.
Hogan, Brad J.
Dixit, Gauri
Berger, Delaney
Su, Wendell R.
Whitfield, Matthew J.
Varsanik, Jonathan S.
Foroohar, Mani
Zappala, Stephen M.
Chander, Ashok C.
Sant, Grannum R.
机构：
[1] Associated Med Profess New York PLLC, Syracuse, NY USA
[2] Florida Hosp, Orlando, FL USA
[3] Lahey Hosp & Med Ctr, Burlington, MA USA
[4] Urology Pl, San Antonio, TX USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Cellanyx Diagnost, Beverly, MA USA
[8] Lahey Clin Fdn, Andover Urol, Andover, MA USA
[9] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.338
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
338
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A novel live cell platform diagnostic utilizing phenotypic biomarkers for assessing prostate cancer aggressiveness.
    Knope, Kevin B.
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Rashid, Hani H.
    Mouraviev, Vladimir
    Manak, Michael S.
    Hogan, Brad J.
    Dixlt, Gauri
    Su, Wendell R.
    Berger, Delaney
    Whitfield, Matthew J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Zappala, Stephen M.
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] A novel live cell platform utilizing phenotypic biophysical and molecular biomarkers for assessing prostate cancer aggressiveness.
    Knopf, Kevin B.
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Hernandez, Ray
    Rashid, Hani H.
    Mouraviev, Vladimir
    Manak, Michael S.
    Su, Wendell R.
    Min, Andrew
    Berger, Delaney
    Hogan, Brad J.
    Saphirstein, Robert J.
    Whitfield, Matt J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Novel live tumor cell diagnostic test utilizing biophysical and molecular biomarkers to assess local, advanced, and metastatic prostate cancer.
    Knopf, Kevin B.
    Manak, Michael S.
    Su, Wendell R.
    Meyyappan, Thiagarajan
    Min, Andrew
    Saphirstein, Robert J.
    Hogan, Brad J.
    Whitfield, Matt J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Kella, Naveen
    Hernandez, Ray
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Rashid, Hani H.
    Mouraviev, Vladimir
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [4] BIOMARKERS OF PROSTATE CANCER. A REVIEW
    Mearini, E.
    Cottini, E.
    Cochetti, G.
    Antognelli, C.
    Talesa, V.
    [J]. MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (02) : 163 - 178
  • [5] Live cell in vitro prognostic utilizing biophysical and molecular biomarkers for measuring local growth and metastatic potential in prostate cancer
    Chander, Ashok C.
    Manak, Michael S.
    Ramu, Senthil K.
    Su, Wendell R.
    Meyyappan, Thiagu
    Hogan, Brad J.
    Whitfield, Matt J.
    Varsanik, Jonathan S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] A NOVEL LIVE CELL MICROFLUIDIC DIAGNOSTIC USING PHENOTYPIC BIOMARKERS WITH OBJECTIVE ALGORITHMIC ANALYSIS FOR PROSTATE CANCER RISK STRATIFICATION.
    Rieger-Christ, Kimberly
    Sullivan, Travis
    Kella, Naveen
    Hernandez, Ray
    Mouraviev, Vladimir
    Knopf, Kevin
    Rashid, Hani
    Manak, Michael
    Su, Wendell
    Hogan, Brad
    Min, Andrew
    Berger, Delaney
    Whitfield, Matthew
    Varsanik, Jonathan
    Foroohar, Mani
    Chander, Ashok
    Albala, David
    Sant, Grannum
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E8 - E9
  • [7] Current state of genetic biomarkers for prostate cancer.
    Cooper, Meghan Anastasia
    Lee, Jae K.
    Pow-Sang, Julio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [8] Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
    Grannum R. Sant
    Kevin B. Knopf
    David M. Albala
    [J]. npj Precision Oncology, 1
  • [9] Consensus statement on circulating biomarkers for advanced prostate cancer.
    Sumanasuriya, Semini
    Omlin, Aurelius Gabriel
    Armstrong, Andrew J.
    Attard, Gerhardt
    Chi, Kim N.
    Bevan, Charlotte L.
    Waugh, David J.
    Ijzerman, Maarten J.
    De Laere, Bram
    Lolkema, Martijn P.
    Lorente, David
    Luo, Jun
    Mehra, Niven
    Olmos, David
    Scher, Howard I.
    Soule, Howard R.
    Stoecklein, Nikolas H.
    Terstappen, Leon W. M. M.
    De Bono, Johann S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] Biomarkers for prostate cancer.: Molecular approaches to assess prognosis
    Perner, S.
    Mertz, K. D.
    Kuefer, R.
    Rubin, M. A.
    [J]. ONKOLOGE, 2007, 13 (08): : 669 - +
12345